Connection
Charles Daley to Costs and Cost Analysis
This is a "connection" page, showing publications Charles Daley has written about Costs and Cost Analysis.
|
|
Connection Strength |
|
|
|
|
|
0.014 |
|
|
|
-
Jasmer RM, Snyder DC, Saukkonen JJ, Hopewell PC, Bernardo J, King MD, Kawamura LM, Daley CL. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trial. Clin Infect Dis. 2004 Feb 01; 38(3):363-9.
Score: 0.014